skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Abstract

Polycomb repressive complex 2 (PRC2) is a regulator of epigenetic states required for development and homeostasis. PRC2 trimethylates histone H3 at lysine 27 (H3K27me3), which leads to gene silencing, and is dysregulated in many cancers. The embryonic ectoderm development (EED) protein is an essential subunit of PRC2 that has both a scaffolding function and an H3K27me3-binding function. Here we report the identification of A-395, a potent antagonist of the H3K27me3 binding functions of EED. Structural studies demonstrate that A-395 binds to EED in the H3K27me3-binding pocket, thereby preventing allosteric activation of the catalytic activity of PRC2. Phenotypic effects observed in vitro and in vivo are similar to those of known PRC2 enzymatic inhibitors; however, A-395 retains potent activity against cell lines resistant to the catalytic inhibitors. A-395 represents a first-in-class antagonist of PRC2 protein–protein interactions (PPI) for use as a chemical probe to investigate the roles of EED-containing protein complexes.

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ORCiD logo; ; « less
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
INDUSTRY
OSTI Identifier:
1351368
Resource Type:
Journal Article
Resource Relation:
Journal Name: Nature Chemical Biology; Journal Volume: 13; Journal Issue: 4
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

He, Yupeng, Selvaraju, Sujatha, Curtin, Michael L., Jakob, Clarissa G., Zhu, Haizhong, Comess, Kenneth M., Shaw, Bailin, The, Juliana, Lima-Fernandes, Evelyne, Szewczyk, Magdalena M., Cheng, Dong, Klinge, Kelly L., Li, Huan-Qiu, Pliushchev, Marina, Algire, Mikkel A., Maag, David, Guo, Jun, Dietrich, Justin, Panchal, Sanjay C., Petros, Andrew M., Sweis, Ramzi F., Torrent, Maricel, Bigelow, Lance J., Senisterra, Guillermo, Li, Fengling, Kennedy, Steven, Wu, Qin, Osterling, Donald J., Lindley, David J., Gao, Wenqing, Galasinski, Scott, Barsyte-Lovejoy, Dalia, Vedadi, Masoud, Buchanan, Fritz G., Arrowsmith, Cheryl H., Chiang, Gary G., Sun, Chaohong, and Pappano, William N.. The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex. United States: N. p., 2017. Web. doi:10.1038/nchembio.2306.
Copy to clipboard
He, Yupeng, Selvaraju, Sujatha, Curtin, Michael L., Jakob, Clarissa G., Zhu, Haizhong, Comess, Kenneth M., Shaw, Bailin, The, Juliana, Lima-Fernandes, Evelyne, Szewczyk, Magdalena M., Cheng, Dong, Klinge, Kelly L., Li, Huan-Qiu, Pliushchev, Marina, Algire, Mikkel A., Maag, David, Guo, Jun, Dietrich, Justin, Panchal, Sanjay C., Petros, Andrew M., Sweis, Ramzi F., Torrent, Maricel, Bigelow, Lance J., Senisterra, Guillermo, Li, Fengling, Kennedy, Steven, Wu, Qin, Osterling, Donald J., Lindley, David J., Gao, Wenqing, Galasinski, Scott, Barsyte-Lovejoy, Dalia, Vedadi, Masoud, Buchanan, Fritz G., Arrowsmith, Cheryl H., Chiang, Gary G., Sun, Chaohong, & Pappano, William N.. The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex. United States. doi:10.1038/nchembio.2306.
Copy to clipboard
He, Yupeng, Selvaraju, Sujatha, Curtin, Michael L., Jakob, Clarissa G., Zhu, Haizhong, Comess, Kenneth M., Shaw, Bailin, The, Juliana, Lima-Fernandes, Evelyne, Szewczyk, Magdalena M., Cheng, Dong, Klinge, Kelly L., Li, Huan-Qiu, Pliushchev, Marina, Algire, Mikkel A., Maag, David, Guo, Jun, Dietrich, Justin, Panchal, Sanjay C., Petros, Andrew M., Sweis, Ramzi F., Torrent, Maricel, Bigelow, Lance J., Senisterra, Guillermo, Li, Fengling, Kennedy, Steven, Wu, Qin, Osterling, Donald J., Lindley, David J., Gao, Wenqing, Galasinski, Scott, Barsyte-Lovejoy, Dalia, Vedadi, Masoud, Buchanan, Fritz G., Arrowsmith, Cheryl H., Chiang, Gary G., Sun, Chaohong, and Pappano, William N.. Mon . "The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex". United States. doi:10.1038/nchembio.2306.
Copy to clipboard
@article{osti_1351368,
title = {The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex},
author = {He, Yupeng and Selvaraju, Sujatha and Curtin, Michael L. and Jakob, Clarissa G. and Zhu, Haizhong and Comess, Kenneth M. and Shaw, Bailin and The, Juliana and Lima-Fernandes, Evelyne and Szewczyk, Magdalena M. and Cheng, Dong and Klinge, Kelly L. and Li, Huan-Qiu and Pliushchev, Marina and Algire, Mikkel A. and Maag, David and Guo, Jun and Dietrich, Justin and Panchal, Sanjay C. and Petros, Andrew M. and Sweis, Ramzi F. and Torrent, Maricel and Bigelow, Lance J. and Senisterra, Guillermo and Li, Fengling and Kennedy, Steven and Wu, Qin and Osterling, Donald J. and Lindley, David J. and Gao, Wenqing and Galasinski, Scott and Barsyte-Lovejoy, Dalia and Vedadi, Masoud and Buchanan, Fritz G. and Arrowsmith, Cheryl H. and Chiang, Gary G. and Sun, Chaohong and Pappano, William N.},
abstractNote = {Polycomb repressive complex 2 (PRC2) is a regulator of epigenetic states required for development and homeostasis. PRC2 trimethylates histone H3 at lysine 27 (H3K27me3), which leads to gene silencing, and is dysregulated in many cancers. The embryonic ectoderm development (EED) protein is an essential subunit of PRC2 that has both a scaffolding function and an H3K27me3-binding function. Here we report the identification of A-395, a potent antagonist of the H3K27me3 binding functions of EED. Structural studies demonstrate that A-395 binds to EED in the H3K27me3-binding pocket, thereby preventing allosteric activation of the catalytic activity of PRC2. Phenotypic effects observed in vitro and in vivo are similar to those of known PRC2 enzymatic inhibitors; however, A-395 retains potent activity against cell lines resistant to the catalytic inhibitors. A-395 represents a first-in-class antagonist of PRC2 protein–protein interactions (PPI) for use as a chemical probe to investigate the roles of EED-containing protein complexes.},
doi = {10.1038/nchembio.2306},
journal = {Nature Chemical Biology},
number = 4,
volume = 13,
place = {United States},
year = {Mon Jan 30 00:00:00 EST 2017},
month = {Mon Jan 30 00:00:00 EST 2017}
}
Copy to clipboard
Journal Article:
DOI:  10.1038/nchembio.2306
Other availability
Find in Google Scholar Find in Google Scholar
Search WorldCat Search WorldCat to find libraries that may hold this journal
Save / Share:
Export Metadata
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.

  • ; ; ; ... - Bioorganic and Medicinal Chemistry Letters

  • ; ; ; ... - Journal of Medicinal Chemistry
    PRC2 is a multisubunit methyltransferase involved in epigenetic regulation of early embryonic development and cell growth. The catalytic subunit EZH2 methylates primarily lysine 27 of histone H3, leading to chromatin compaction and repression of tumor suppressor genes. Inhibiting this activity by small molecules targeting EZH2 was shown to result in antitumor efficacy. Here, we describe the optimization of a chemical series representing a new class of PRC2 inhibitors which acts allosterically via the trimethyllysine pocket of the noncatalytic EED subunit. Deconstruction of a larger and complex screening hit to a simple fragment-sized molecule followed by structure-guided regrowth and careful propertymore » modulation were employed to yield compounds which achieve submicromolar inhibition in functional assays and cellular activity. The resulting molecules can serve as a simplified entry point for lead optimization and can be utilized to study this new mechanism of PRC2 inhibition and the associated biology in detail.« less

  • ; ; ; ... - ACS Combinatorial Science
    The function of EED within polycomb repressive complex 2 (PRC2) is mediated by a complex network of protein–protein interactions. Allosteric activation of PRC2 by binding of methylated proteins to the embryonic ectoderm development (EED) aromatic cage is essential for full catalytic activity, but details of this regulation are not fully understood. EED’s recognition of the product of PRC2 activity, histone H3 lysine 27 trimethylation (H3K27me3), stimulates PRC2 methyltransferase activity at adjacent nucleosomes leading to H3K27me3 propagation and, ultimately, gene repression. By coupling combinatorial chemistry and structure-based design, we optimized a low-affinity methylated jumonji, AT-rich interactive domain 2 (Jarid2) peptide tomore » a smaller, more potent peptidomimetic ligand (K d = 1.14 ± 0.14 μM) of the aromatic cage of EED. Our strategy illustrates the effectiveness of applying combinatorial chemistry to achieve both ligand potency and property optimization. Furthermore, the resulting ligands, UNC5114 and UNC5115, demonstrate that targeted disruption of EED’s reader function can lead to allosteric inhibition of PRC2 catalytic activity.« less

  • ; ; ; ... - Biochemical and Biophysical Research Communications
    Highlights: Black-Right-Pointing-Pointer We designed novel recombinant albumin-RBP fusion proteins. Black-Right-Pointing-Pointer Expression of fusion proteins inactivates pancreatic stellate cells (PSCs). Black-Right-Pointing-Pointer Fusion proteins are successfully internalized into and inactivate PSCs. Black-Right-Pointing-Pointer RBP moiety mediates cell specific uptake of fusion protein. -- Abstract: Quiescent pancreatic- (PSCs) and hepatic- (HSCs) stellate cells store vitamin A (retinol) in lipid droplets via retinol binding protein (RBP) receptor and, when activated by profibrogenic stimuli, they transform into myofibroblast-like cells which play a key role in the fibrogenesis. Despite extensive investigations, there is, however, currently no appropriate therapy available for tissue fibrosis. We previously showed that themore » expression of albumin, composed of three homologous domains (I-III), inhibits stellate cell activation, which requires its high-affinity fatty acid-binding sites asymmetrically distributed in domain I and III. To attain stellate cell-specific uptake, albumin (domain I/III) was coupled to RBP; RBP-albumin{sup domain} {sup III} (R-III) and albumin{sup domain} {sup I}-RBP-albumin{sup III} (I-R-III). To assess the biological activity of fusion proteins, cultured PSCs were used. Like wild type albumin, expression of R-III or I-R-III in PSCs after passage 2 (activated PSCs) induced phenotypic reversal from activated to fat-storing cells. On the other hand, R-III and I-R-III, but not albumin, secreted from transfected 293 cells were successfully internalized into and inactivated PSCs. FPLC-purified R-III was found to be internalized into PSCs via caveolae-mediated endocytosis, and its efficient cellular uptake was also observed in HSCs and podocytes among several cell lines tested. Moreover, tissue distribution of intravenously injected R-III was closely similar to that of RBP. Therefore, our data suggest that albumin-RBP fusion protein comprises of stellate cell inactivation-inducing moiety and targeting moiety, which may lead to the development of effective anti-fibrotic drug.« less

  • ; ; ; ... - Nature (London)
    The Polycomb repressive complex 2 (PRC2) mainly mediates transcriptional repression1,2 and has essential roles in various biological processes including the maintenance of cell identity and proper differentiation. Polycomb-like (PCL) proteins, such as PHF1, MTF2 and PHF19, are PRC2-associated factors that form sub-complexes with PRC2 core components3, and have been proposed to modulate the enzymatic activity of PRC2 or the recruitment of PRC2 to specific genomic loci4,5,6,7,8,9,10,11,12,13. Mammalian PRC2-binding sites are enriched in CG content, which correlates with CpG islands that display a low level of DNA methylation14. However, the mechanism of PRC2 recruitment to CpG islands is not fully understood.more » Here we solve the crystal structures of the N-terminal domains of PHF1 and MTF2 with bound CpG-containing DNAs in the presence of H3K36me3-containing histone peptides. We show that the extended homologous regions of both proteins fold into a winged-helix structure, which specifically binds to the unmethylated CpG motif but in a completely different manner from the canonical winged-helix DNA recognition motif. We also show that the PCL extended homologous domains are required for efficient recruitment of PRC2 to CpG island-containing promoters in mouse embryonic stem cells. Our research provides the first, to our knowledge, direct evidence to demonstrate that PCL proteins are crucial for PRC2 recruitment to CpG islands, and further clarifies the roles of these proteins in transcriptional regulation in vivo.« less